Atlas Trials

Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications

Clinical trial NCT04403087 · COMPLETED

Trial details

NCT number
NCT04403087
Sponsor
Chuncheon Sacred Heart Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2021-05-01
Primary completion
2021-06-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.